tert-butyl N-[(2S)-3-methyl-1-[[(1R)-2-[(2S)-2-[5-[13-[2-[(2S)-1-[(2R)-2-[[(2S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoyl]amino]-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]amino]-1-oxobutan-2-yl]carbamate | 1377046-36-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl N-[(2S)-3-methyl-1-[[(1R)-2-[(2S)-2-[5-[13-[2-[(2S)-1-[(2R)-2-[[(2S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoyl]amino]-2-phenylacetyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]amino]-1-oxobutan-2-yl]carbamate
• CAS: 1377046-36-0
• 化学式: C₆₄H₇₆N₁₀O₁₀
• 分子量: 1145.37
• InChiKey: MCTLURCOIJKTIF-UCSCQXQQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.2
• 重原子数：
  84
• 可旋转键数：
  20
• 环数：
  10.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  251
• 氢给体数：
  6
• 氢受体数：
  12

文献信息

• ANTIVIRAL COMPOUNDS
  申请人：Bacon Elizabeth M.

  公开号：US20140018313A1

  公开（公告）日：2014-01-16

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  本发明涉及抗病毒化合物、含有这种化合物的组合物、包括给予这种化合物的治疗方法，以及用于制备这种化合物的有用过程和中间体。
• Antiviral compounds
  申请人：GILEAD PHARMASSET LLC

  公开号：US10344019B2

  公开（公告）日：2019-07-09

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  本发明涉及抗病毒化合物、含有此类化合物的组合物、包括施用此类化合物的治疗方法，以及制备此类化合物的工艺和中间体。
• US9156823B2
  申请人：——

  公开号：US9156823B2

  公开（公告）日：2015-10-13
• [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
  申请人：GILEAD SCIENCES INC

  公开号：WO2012068234A2

  公开（公告）日：2012-05-24

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.